Biotech IPOs: Rewards Worth The Risk
This article was originally published in Start Up
Executive Summary
An analysis by START-UP reveals that newly public companies are raising more money (on average) than comparable companies who remained private, even if total dollars for the pool of public firms is dwarfed by the total amount raised by their private brethren.